Literature DB >> 16769868

Cognitive measures predict pathologic Alzheimer disease.

Matthew R Powell1, Glenn E Smith, David S Knopman, Joseph E Parisi, Bradley F Boeve, Ronald C Petersen, Robert J Ivnik.   

Abstract

BACKGROUND: Neuropsychologic testing is often used to infer neuropathologic processes, but clinicopathologic correlations for individual cognitive measures are based on a small number of published studies.
OBJECTIVE: To examine the usefulness of the age- and education-adjusted Mayo Cognitive Factor Scales (MCFS) obtained at participants' initial assessments for predicting the presence or absence of pathologic Alzheimer disease (AD).
DESIGN: This was a longitudinal study of a cohort of elderly patients with and without cognitive complaints who were followed up until death. Mayo Cognitive Factor Scales age- and education-adjusted standard scores from the participants' initial evaluations were used to calculate classification accuracy statistics for neuropathologic AD diagnosis obtained approximately 6 years after testing. Subjects with non-AD diagnoses or substantial non-AD-related changes were excluded from the study.
SETTING: Academic medical center. PARTICIPANTS: One hundred two participants were evaluated clinically and underwent neuropathologic examination at autopsy. All were part of the Mayo Clinic Alzheimer's Disease Patient Registry or Alzheimer Disease Research Center.
RESULTS: All Mayo Cognitive Factor Scale scores were significantly correlated with AD criteria. Logistic regression modeling including Mayo Cognitive Factor Scales Verbal Comprehension and Retention indices revealed high positive predictive value with moderate sensitivity and specificity for pathologic AD.
CONCLUSION: Neuropsychologic test scores at initial evaluations were predictive of pathologic AD.

Entities:  

Mesh:

Year:  2006        PMID: 16769868     DOI: 10.1001/archneur.63.6.865

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  17 in total

1.  Increased functional brain response during word retrieval in cognitively intact older adults at genetic risk for Alzheimer's disease.

Authors:  Christina E Wierenga; Nikki H Stricker; Ashley McCauley; Alan Simmons; Amy J Jak; Yu-Ling Chang; Lisa Delano-Wood; Katherine J Bangen; David P Salmon; Mark W Bondi
Journal:  Neuroimage       Date:  2010-03-16       Impact factor: 6.556

Review 2.  Neuropsychological contributions to the early identification of Alzheimer's disease.

Authors:  Mark W Bondi; Amy J Jak; Lisa Delano-Wood; Mark W Jacobson; Dean C Delis; David P Salmon
Journal:  Neuropsychol Rev       Date:  2008-03-18       Impact factor: 7.444

3.  Robust and conventional neuropsychological norms: diagnosis and prediction of age-related cognitive decline.

Authors:  Susan De Santi; Elizabeth Pirraglia; William Barr; James Babb; Schantel Williams; Kimberley Rogers; Lidia Glodzik; Miroslaw Brys; Lisa Mosconi; Barry Reisberg; Steven Ferris; Mony J de Leon
Journal:  Neuropsychology       Date:  2008-07       Impact factor: 3.295

Review 4.  Positron emission tomography scans obtained for the evaluation of cognitive dysfunction.

Authors:  Daniel H S Silverman; Lisa Mosconi; Linda Ercoli; Wei Chen; Gary W Small
Journal:  Semin Nucl Med       Date:  2008-07       Impact factor: 4.446

Review 5.  Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging.

Authors:  Lisa Mosconi; Valentina Berti; Lidia Glodzik; Alberto Pupi; Susan De Santi; Mony J de Leon
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

6.  Latent information in fluency lists predicts functional decline in persons at risk for Alzheimer disease.

Authors:  D G Clark; P Kapur; D S Geldmacher; J C Brockington; L Harrell; T P DeRamus; P D Blanton; K Lokken; A P Nicholas; D C Marson
Journal:  Cortex       Date:  2014-01-16       Impact factor: 4.027

Review 7.  Neuropsychological assessment of patients with dementing illness.

Authors:  Julie A Fields; Tanis J Ferman; Bradley F Boeve; Glenn E Smith
Journal:  Nat Rev Neurol       Date:  2011-11-01       Impact factor: 42.937

8.  Which neuropsychological tests predict progression to Alzheimer's disease in Hispanics?

Authors:  Gali H Weissberger; David P Salmon; Mark W Bondi; Tamar H Gollan
Journal:  Neuropsychology       Date:  2013-05       Impact factor: 3.295

9.  Heterogeneity in mild cognitive impairment: differences in neuropsychological profile and associated white matter lesion pathology.

Authors:  Lisa Delano-Wood; Mark W Bondi; Joshua Sacco; Norm Abeles; Amy J Jak; David J Libon; Andrea Bozoki
Journal:  J Int Neuropsychol Soc       Date:  2009-11       Impact factor: 2.892

10.  Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies.

Authors:  Rachel Mistur; Lisa Mosconi; Susan De Santi; Marla Guzman; Yi Li; Wai Tsui; Mony J de Leon
Journal:  J Clin Neurol       Date:  2009-12-31       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.